Gyroscope Therapeutics
Biotechnology, 11-21 Northdown Street, London, California, 94061, United States, 51-200 Employees
Who is GYROSCOPE THERAPEUTICS
About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye...
Read More
-
Headquarters: 11-21 Northdown Street, London, California, 94061, United States
-
Date Founded: 2016
-
Employees: 51-200
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from GYROSCOPE THERAPEUTICS
Gyroscope Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Gyroscope Therapeutics
Answer: Gyroscope Therapeutics's headquarters are located at 11-21 Northdown Street, London, California, 94061, United States
Answer: Gyroscope Therapeutics's official website is https://gyroscopetx.com
Answer: Gyroscope Therapeutics's revenue is $1 Million to $5 Million
Answer: Gyroscope Therapeutics's SIC: 2836
Answer: Gyroscope Therapeutics's NAICS: 541714
Answer: Gyroscope Therapeutics has 51-200 employees
Answer: Gyroscope Therapeutics is in Biotechnology
Answer: Gyroscope Therapeutics contact info: Phone number: Website: https://gyroscopetx.com
Answer: About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022. Gyroscope’s lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. Food and Drug Administration for the treatment of people with GA. Guided by a mission to preserve sight and fight the devastating impact of blindness, Gyroscope has built a global organisation combining discovery, research, drug development, a manufacturing platform and surgical delivery capabilities.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month